---
figid: PMC9320771__cancers-14-03305-g001
figtitle: Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast
  Cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9320771
filename: cancers-14-03305-g001.jpg
figlink: /pmc/articles/PMC9320771/figure/cancers-14-03305-f001/
number: F1
caption: 'Interaction between estrogen receptor (ER) and human epidermal growth factor
  -2 (HER2) pathways. In ER+/HER2+ tumors, the hyperactivation of HER2 signaling activates
  downstream kinases and downregulates ER expression, not only at the protein level
  but also at mRNA expression. EGFR: epidermal growth factor receptor; HER3: human
  epidermal growth factor -3; HER4: human epidermal growth factor -4; P: phosphorylated;
  MAPK: mitogen-activated protein kinase; PI3K: phosphoinositide-3-kinase; CoA: coactivator;
  G-protein: Guanine nucleotide binding protein; AKT: protein kinase B; SRC: steroid
  receptor coactivator. (Adapted from “HER2 Signaling Pathway”, by BioRender.com (2022).
  Retrieved from https://app.biorender.com/biorender-templates, accessed on 1 July
  2022).'
papertitle: Targeted Therapeutic Options and Future Perspectives for HER2-Positive
  Breast Cancer.
reftext: Angelica Ferrando-Díez, et al. Cancers (Basel). 2022 Jul;14(14):3305.
year: '2022'
doi: 10.3390/cancers14143305
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: breast cancer | HER2-positive | estrogen receptor positive | triple-positive
  | HER2-targeted therapy | immunotherapy
automl_pathway: 0.9643939
figid_alias: PMC9320771__F1
figtype: Figure
redirect_from: /figures/PMC9320771__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9320771__cancers-14-03305-g001.html
  '@type': Dataset
  description: 'Interaction between estrogen receptor (ER) and human epidermal growth
    factor -2 (HER2) pathways. In ER+/HER2+ tumors, the hyperactivation of HER2 signaling
    activates downstream kinases and downregulates ER expression, not only at the
    protein level but also at mRNA expression. EGFR: epidermal growth factor receptor;
    HER3: human epidermal growth factor -3; HER4: human epidermal growth factor -4;
    P: phosphorylated; MAPK: mitogen-activated protein kinase; PI3K: phosphoinositide-3-kinase;
    CoA: coactivator; G-protein: Guanine nucleotide binding protein; AKT: protein
    kinase B; SRC: steroid receptor coactivator. (Adapted from “HER2 Signaling Pathway”,
    by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates,
    accessed on 1 July 2022).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Src42A
  - Csk
  - Src64B
  - Coa
  - MKP-4
  - p38b
  - rl
  - pto
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - her
  - Hesr
  - EGFR
  - SRC
  - FGR
  - FYN
  - YES1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - ERBB2
  - ERBB3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - ERBB4
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
---
